Log In
BCIQ
Print this Print this
 

OD-01

  Manage Alerts
Collapse Summary General Information
Company Oculeve Inc.
DescriptionNasal neurostimulation device that increases tear production
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices
Latest Stage of DevelopmentPilot
Standard IndicationDry eye
Indication DetailsTreat dry eye
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$125.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/10/2015

Undisclosed

$125.0M

Undisclosed

Get a free BioCentury trial today